Laura Hellinen
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Ophthalmology top 5%
- Retinal Diseases and Treatments
- Glaucoma and retinal disorders
Papers in
-
- Adenosine and Purinergic Signaling 2
- Oncology 4
- Drug Transport and Resistance Mechanisms 2
- Peptidase Inhibition and Analysis 2
- Co-authors
- Arto O. Urtti (10 shared papers)Mika Reinisalo (6 shared papers)Heidi Kidron (3 shared papers)Eva Maria del Amo (3 shared papers)Anna‐Kaisa Rimpelä (2 shared papers)Marika Ruponen (5 shared papers)Kati‐Sisko Vellonen (5 shared papers)Marja Hagström (2 shared papers)
- Journals
- Advanced Drug Delivery Reviews (2 papers)Biomedicine & Pharmacotherapy (2 papers)Pharmaceutics (2 papers)European Journal of Pharmaceutics and Biopharmaceutics (1 paper)Journal of Controlled Release (1 paper)
- Partner nations
- FinlandRussiaUnited States
In The Last Decade
Laura Hellinen
11 papers receiving 356 citations
Peers
Comparison fields: 5 of 68
- Pharmaceutical Science 88
- Ophthalmology 92
- Radiology, Nuclear Medicine and Imaging 66
- Public Health, Environmental and Occupational Health 73
- Physiology 10
Countries citing papers authored by Laura Hellinen
This map shows the geographic impact of Laura Hellinen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Hellinen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Hellinen more than expected).
Fields of papers citing papers by Laura Hellinen
This network shows the impact of papers produced by Laura Hellinen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Hellinen. The network helps show where Laura Hellinen may publish in the future.
Co-authors
The 25 scholars most cited alongside Laura Hellinen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 101 | |
| 2 | 2021 | 56 | |
| 3 | 2017 | 54 | |
| 4 | 2020 | 34 | |
| 5 | 2019 | 32 | |
| 6 | 2020 | 27 | |
| 7 | 2019 | 21 | |
| 8 | 2022 | 17 | |
| 9 | 2020 | 10 | |
| 10 | 2021 | 5 | |
| 11 | 2023 | 3 |
About Laura Hellinen
Laura Hellinen is a scholar working on Physiology, Oncology, Ophthalmology, Molecular Biology and Cell Biology, having authored 11 papers that have together received 360 indexed citations. Recurring topics across this work include Protein Interaction Studies and Fluorescence Analysis (3 papers), Retinal Development and Disorders (3 papers), Adenosine and Purinergic Signaling (2 papers), melanin and skin pigmentation (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Retinal Diseases and Treatments (2 papers), Peptidase Inhibition and Analysis (2 papers) and Ocular Diseases and Behçet’s Syndrome (1 paper). The work is most often cited by research in Pharmaceutical Science (88 citations), Ophthalmology (92 citations), Radiology, Nuclear Medicine and Imaging (66 citations), Public Health, Environmental and Occupational Health (73 citations) and Physiology (10 citations). Laura Hellinen has collaborated with scholars based in Finland, Russia and United States. Frequent co-authors include Arto O. Urtti, Mika Reinisalo, Heidi Kidron, Eva Maria del Amo, Anna‐Kaisa Rimpelä, Marika Ruponen, Kati‐Sisko Vellonen, Marja Hagström, Eliisa Mannermaa and Seppo O. K. Auriola. Their work appears in journals such as Advanced Drug Delivery Reviews, Biomedicine & Pharmacotherapy, Pharmaceutics, European Journal of Pharmaceutics and Biopharmaceutics and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.